Navigation Links
AV-1011 Bird Repellent to Protect Rice Seed Approved for Use in Louisiana and Missouri
Date:3/12/2009

NEW CASTLE, Del., March 12 /PRNewswire/ ---- Arkion(R) Life Sciences has received their first ever Section 18 approvals to market AV-1011 Liquid Rice Seed Treatment in Louisiana and Missouri effective March 6, 2009, through March 6, 2010. The EPA approval means that rice growers in these states can protect their seed from marauding blackbirds and grackles. The new bird repellent effectively stops birds from eating the newly planted seeds and reducing rice yields.

While the product is non-lethal to birds, it has been shown to be highly effective in protecting rice seed during several years of testing. According to Michael Hensgens, Business Manager, G&H Seed Company (Crowley, LA), this allows Louisiana rice producers to plant before over-wintering blackbirds have migrated north. Early planting has several advantages. In the past, many rice producers have delayed planting to avoid the risk of newly planted seeds being eaten by birds. Resulting damage to rice fields causes lower yields and sometimes requires replanting -- both of which are very costly. It also allows producers to plant at a more optimal date which usually results in higher yields. Another real advantage to earlier planting and harvest is reduced hurricane risk. Hurricane Rita in 2005 and Gustave and Ike in 2008 caused massive crop losses to rice not harvested by Labor Day. An early planting date allows producers to complete harvest by August.

Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site: www.ArkionLS.com.

Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. In addition to Avipel(R) for crop protection, Arkion's patented formulations of anthraquinone effectively repel geese from turf grass with FlightControl(R) Plus and birds from structures through Airepel(R) Humane Bird Management.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. Arkion(R) has three major businesses:

Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.


'/>"/>
SOURCE Arkion Life Sciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ORNL super water repellent could cause big wave in market
2. Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System
3. InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
4. N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency
5. vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque
6. Cain and Associates Launches Government Audit Protection (GAP) Service
7. Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
8. Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
9. New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric
10. UCF professor develops vaccine to protect against black plague bioterror attack
11. SRA Awarded $56 Million Contract by Pentagon Force Protection Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 20, 2017 Stock-Callers.com explores the ... influenced the most recent performances of select equities. In ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... ), and Sage Therapeutics Inc. (NASDAQ: SAGE ... View Research, global Biotech market size is expected to reach $604.40 billion by ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets has ... Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry ... ... the global market is projected to reach $15,737 million by 2022 ... 2016 to 2022. Omic technologies segment accounted for ...
(Date:1/19/2017)... Research and Markets ... announced the addition of the "Implantable Biomaterials Market ... report to their offering. Report Highlights: ... analysis on current and future market trends to identify the investment opportunities ... the base numbers Key market trends across the business ...
(Date:1/19/2017)... 19, 2017  ArmaGen, Inc., today announced that ... as chief executive officer, as well as a ... to ArmaGen more than 17 years of executive ... of biotherapeutics and pharmaceuticals. "Mathias ... experience and skillset necessary to lead ArmaGen to ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):